Sickle cell anemia/sickle cell disease and pregnancy outcomes among ethnic tribes in India: an integrative mini-review

References

• Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031.
   PubMed Web of Science ®Google Scholar
• Panepinto JA, Brousseau DC, Hillery CA, et al. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer. 2005;44(2):182–186.
   PubMed Web of Science ®Google Scholar
• Colah RB, Mehta P, Mukherjee MB. Newborn screening for sickle cell disease: Indian experience. Int J Neonatal Screen. 2018;4(4):31.
   PubMed Web of Science ®Google Scholar
• Serjeant GR, Ghosh K, Patel J. Sickle cell disease in India: a perspective. Indian J Med Res. 2016;143(1):21–24.
   PubMedGoogle Scholar
• Johnston TA. Haemoglobinopathies in pregnancy. ObstetGynaecol. 2005;7(3):149–157.
   Google Scholar
• Piel FB, Patil AP, Howes RE, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1:104.
   PubMed Web of Science ®Google Scholar
• Urade BP. Haemoglobin S and β (Thal): their distribution in Maharashtra, India. Int J Biomed Sci. 2013;9(2):75–81.
   PubMedGoogle Scholar
• Rao VR. Genetics and epidemiology of sickle cell anemia in India. Indian J Med Sci. 1988;42(9):218–222.
   PubMedGoogle Scholar
• Desai G, Dave KK, Banerjee S, et al. Initial outcomes of a comprehensive care model for sickle cell disease among a tribal population in rural western India. Int J Community Med Public Health. 2016;3:1282–1287.
   Google Scholar
• Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142–151.
   PubMed Web of Science ®Google Scholar
• Ahmed SG, Ibrahim UA. A compendium of pathophysiologic basis of etiologic risk factors for painful vaso-occlusive crisis in sickle cell disease. Niger J Basic Clin Sci. 2017;14(2):57–77.
   Google Scholar
• Luzzatto L. Sickle cell anaemia and malaria. Mediterr J Hematol Infect Dis. 2012;4(1):e2012065.
   PubMedGoogle Scholar
• Census of India. 2011. Office of the Registrar General and Census Commissioner. Ministry of Home Affairs, Govt of India. [cited 2015 Mar 27]. Available from: http://www.censusindia.gov.in.
   Google Scholar
• Kumar MM, Pathak VK, Ruikar M. Tribal population in India: a public health challenge and road to future. J Family Med Prim Care. 2020;9(2):508–512.
   PubMedGoogle Scholar
• Lehmann H, Cutbush M. Sickle-cell trait in southern India. Br Med J. 1952;1(4755):404–405.
   PubMedGoogle Scholar
• Dunlop KJ, Mozumder UK. The occurrence of sickle cell anaemia among a group of tea garden labourers in Upper Assam. Ind Med Gaz. 1952;87(9):387–391.
   PubMedGoogle Scholar
• Deshmukh P, Garg BS, Garg N, et al. Prevalence of sickle cell disorders in rural Wardha. Indian J Community Med. 2006;31(1):26.
   Google Scholar
• Dixit S, Sahu P, Kar SK, et al. Identification of the hot-spot areas for sickle cell disease using cord blood screening at a district hospital: an Indian perspective. J Community Genet. 2015;6(4):383–387.
   PubMed Web of Science ®Google Scholar
• Kaur M, Das GP, Verma IC. Sickle cell trait & disease among tribal communities in Orissa, Madhya Pradesh & Kerala. Indian J Med Res. 1997;105:111–116.
   PubMed Web of Science ®Google Scholar
• Deore AU, Urade BP. Incidence of sickle cell trait among the Mahar of Raipur, Chhattisgarh. Anthropol. 2013;15:377–378.
   Google Scholar
• Patel Ashwin P, Naik Madhuben R, Shah Nilam M, et al. Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening program. Natl J Community Med. 2012;3:112–117.
   Google Scholar
• Kar BC. Sickle cell disease in India. J Assoc Physicians India. 1991;39(12):954–960.
   PubMedGoogle Scholar
• Mandot S, Khurana VL, Sonesh JK. Sickle cell anemia in Garasiatribals of Rajasthan. Indian Pediatr. 2009;46(3):239–240.
   PubMed Web of Science ®Google Scholar
• Balgir RS. Infant mortality and reproductive wastage associated with different genotypes of haemoglobinopathies in Orissa, India. Ann Hum Biol. 2007;34(1):16–25.
   PubMed Web of Science ®Google Scholar
• Kar TJ, Baru L, Bhoi G, et al. Fetomaternal outcome in sickle cell hemoglobinopathy. GJRA. 2018;7:83–86.
   Google Scholar
• Lervolino LG, Baldin PE, Picado SM, et al. Prevalence of sickle cell disease and sickle cell trait in national neonatal screening studies. Rev Bras Hematol Hemoter. 2011;33(1):49–54.
   PubMedGoogle Scholar
• Balgir RS. A cross-sectional study of hemoglobin disorders in pregnant women attending two urban hospitals in Eastern Coast of Odisha, India. Online J Health Allied Sci. 2014;12:4.
   Google Scholar
• Desai G, Anand A, Shah P, et al. Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India. J Health Popul Nutr. 2017;36(1):3
   PubMedGoogle Scholar
• Serjeant GR, Loy LL, Crowther M, al. Outcome of pregnancy in homozygous sickle cell disease. Obstet Gynecol. 2004;103:1278–1285.
   PubMed Web of Science ®Google Scholar
• Balgir RS. Prevalence of hemolytic anemia and hemoglobinopathies among the pregnant women attending a tertiary hospital in central India. Thal Rep. 2015;5(1):4644.
   Web of Science ®Google Scholar
• Beischer NA. The effects of maternal anemia upon the fetus. J Reprod Med. 1971;6(6):262–263.
   PubMed Web of Science ®Google Scholar
• Koshy M. Sickle cell disease and pregnancy. Blood Rev. 1995;9(3):157–164.
   PubMed Web of Science ®Google Scholar
• Cumming V, Ali S, Forrester T, et al. Asymptomatic bacteriuria in sickle cell disease: a cross-sectional study. BMC Infect Dis. 2006;6(1):46.
   PubMedGoogle Scholar
• Jain D, Atmapoojya P, Colah R, et al. Sickle cell disease and pregnancy. Mediterr J Hematol Infect Dis. 2019;11(1):e2019040
   PubMed Web of Science ®Google Scholar
• Hamali HA, Saboor M. Undiagnosed hemoglobinopathies: a potential threat to the premarital screening program. Pak J Med Sci. 2019;35(6):1611–1615.
   PubMed Web of Science ®Google Scholar
• Balgir RS. Birth control necessary to limit family size in tribal couples with aberrant heterosis of G-6-PD deficiency and sickle cell disorders in India: an urgency of creating awareness and imparting genetic counseling. J Assoc Physicians India. 2010;58:357–362.
   PubMedGoogle Scholar
• Xu K, Shi ZM, Veeck LL, et al. First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia. JAMA. 1999;281(18):1701–1706.
   PubMed Web of Science ®Google Scholar
• Hassell K. Pregnancy and sickle cell disease. Hematol Oncol Clin North Am. 2005;19(5):903–916.
   PubMed Web of Science ®Google Scholar
• Huntsman RG. Haemoglobinopathies in pregnancy. J Clin Pathol Suppl (R Coll Pathol). 1976;29(Suppl 10):42–53.
   Google Scholar
• Aygun B, Padmanabhan S, Paley C, et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42(1):37–43.
   PubMed Web of Science ®Google Scholar
• Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion. 2011;51(8):1732–1739.
   PubMed Web of Science ®Google Scholar
• Miller ST, Kim HY, Weiner DL, et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion. 2013;53(4):704–709.
   PubMed Web of Science ®Google Scholar
• Thurston GB, Henderson NM, Jeng M. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood. Clin Hemorheol Microcirc. 2004;30(2):83–97.
   PubMed Web of Science ®Google Scholar
• Cappelli B, Gluckman E, Ghanem K, et al. Hemoglobinopathies (sickle cell disease and thalassemia). In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies [Internet]. 7th ed. Cham (CH): Springer; 2019. Chapter 79. Available from http://www.ncbi.nlm.nih.gov/books/NBK553928/.
   Google Scholar
• Panepinto JA, Walters MC, Carreras J, et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol. 2007;137(5):479–485.
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110(7):2749–2756.
   PubMed Web of Science ®Google Scholar
• Agrawal RK, Patel RK, Shah V, et al. Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus. 2014;30(2):91–96.
   PubMed Web of Science ®Google Scholar
• Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood. 1999;94(5):1550–1554.
   PubMed Web of Science ®Google Scholar
• Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148(12):932–938.
   PubMed Web of Science ®Google Scholar
• Ryan K, Heeney M. Management of Priapism in Sickle Cell Disease. The New England  pediatric sickle cell consortium, 11 January 2005. http://nepscc.org/2017/wp-content/uploads/2017/06/Priapism-CPG-NEPSCC-Jan-05.pdf
   Google Scholar